DAI-ICHI KAR | STERLING BIOTECH | DAI-ICHI KAR/ STERLING BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 36.9 | -0.0 | - | View Chart |
P/BV | x | 2.6 | 0.1 | 3,434.5% | View Chart |
Dividend Yield | % | 0.7 | 0.0 | - |
DAI-ICHI KAR STERLING BIOTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DAI-ICHI KAR Mar-23 |
STERLING BIOTECH Mar-18 |
DAI-ICHI KAR/ STERLING BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 448 | 7 | 6,617.4% | |
Low | Rs | 255 | 2 | 15,548.8% | |
Sales per share (Unadj.) | Rs | 246.9 | 12.7 | 1,948.1% | |
Earnings per share (Unadj.) | Rs | 24.8 | -36.9 | -67.1% | |
Cash flow per share (Unadj.) | Rs | 34.8 | -27.9 | -124.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 228.1 | 10.1 | 2,250.1% | |
Shares outstanding (eoy) | m | 7.45 | 272.17 | 2.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.4 | 0.3 | 429.2% | |
Avg P/E ratio | x | 14.2 | -0.1 | -12,456.9% | |
P/CF ratio (eoy) | x | 10.1 | -0.2 | -6,706.8% | |
Price / Book Value ratio | x | 1.5 | 0.4 | 371.6% | |
Dividend payout | % | 16.1 | 0 | - | |
Avg Mkt Cap | Rs m | 2,619 | 1,144 | 228.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 157 | 583 | 26.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,839 | 3,449 | 53.3% | |
Other income | Rs m | 64 | 55 | 117.1% | |
Total revenues | Rs m | 1,904 | 3,504 | 54.3% | |
Gross profit | Rs m | 262 | -7,582 | -3.5% | |
Depreciation | Rs m | 75 | 2,457 | 3.0% | |
Interest | Rs m | 30 | 4,397 | 0.7% | |
Profit before tax | Rs m | 221 | -14,381 | -1.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 36 | -4,327 | -0.8% | |
Profit after tax | Rs m | 185 | -10,054 | -1.8% | |
Gross profit margin | % | 14.2 | -219.8 | -6.5% | |
Effective tax rate | % | 16.5 | 30.1 | 54.7% | |
Net profit margin | % | 10.0 | -291.5 | -3.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 685 | 4,807 | 14.2% | |
Current liabilities | Rs m | 577 | 56,226 | 1.0% | |
Net working cap to sales | % | 5.8 | -1,490.7 | -0.4% | |
Current ratio | x | 1.2 | 0.1 | 1,387.6% | |
Inventory Days | Days | 117 | 1,685 | 6.9% | |
Debtors Days | Days | 530 | 543 | 97.6% | |
Net fixed assets | Rs m | 1,984 | 65,836 | 3.0% | |
Share capital | Rs m | 75 | 272 | 27.4% | |
"Free" reserves | Rs m | 1,625 | 2,486 | 65.3% | |
Net worth | Rs m | 1,699 | 2,759 | 61.6% | |
Long term debt | Rs m | 173 | 19,787 | 0.9% | |
Total assets | Rs m | 2,668 | 70,643 | 3.8% | |
Interest coverage | x | 8.3 | -2.3 | -364.3% | |
Debt to equity ratio | x | 0.1 | 7.2 | 1.4% | |
Sales to assets ratio | x | 0.7 | 0 | 1,411.8% | |
Return on assets | % | 8.1 | -8.0 | -100.7% | |
Return on equity | % | 10.9 | -364.5 | -3.0% | |
Return on capital | % | 13.4 | -44.3 | -30.3% | |
Exports to sales | % | 51.2 | 22.8 | 224.9% | |
Imports to sales | % | 15.0 | 0.6 | 2,512.5% | |
Exports (fob) | Rs m | 942 | 785 | 119.9% | |
Imports (cif) | Rs m | 275 | 21 | 1,339.7% | |
Fx inflow | Rs m | 942 | 785 | 119.9% | |
Fx outflow | Rs m | 275 | 26 | 1,048.4% | |
Net fx | Rs m | 667 | 759 | 87.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 232 | -328 | -70.7% | |
From Investments | Rs m | -326 | -91 | 356.1% | |
From Financial Activity | Rs m | 135 | 384 | 35.0% | |
Net Cashflow | Rs m | 39 | -35 | -110.5% |
Indian Promoters | % | 63.9 | 24.6 | 259.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 21.9 | - | |
FIIs | % | 0.0 | 7.5 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 36.1 | 75.4 | 47.9% | |
Shareholders | 5,085 | 35,184 | 14.5% | ||
Pledged promoter(s) holding | % | 0.0 | 55.9 | - |
Compare DAI-ICHI KAR With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES ALKYL AMINES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | DAI-ICHI KAR | Sterling Biotech |
---|---|---|
1-Day | -0.79% | -4.94% |
1-Month | -4.48% | 6.94% |
1-Year | 52.43% | -78.61% |
3-Year CAGR | 17.94% | -46.43% |
5-Year CAGR | 22.24% | -32.29% |
* Compound Annual Growth Rate
Here are more details on the DAI-ICHI KAR share price and the Sterling Biotech share price.
Moving on to shareholding structures...
The promoters of DAI-ICHI KAR hold a 63.9% stake in the company. In case of Sterling Biotech the stake stands at 24.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DAI-ICHI KAR and the shareholding pattern of Sterling Biotech.
Finally, a word on dividends...
In the most recent financial year, DAI-ICHI KAR paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.1%.
Sterling Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of DAI-ICHI KAR, and the dividend history of Sterling Biotech.
After opening the day marginally higher, Indian share markets reversed the trend as the session progressed and ended the day lower.